Potential beneficial effects of intermittent fasting against cancer risk and management: Novel evidence rendering autophagy as a promising therapeutic target
More details
Hide details
Department of Food Science and Nutrition, School of the Environment, University of the Aegean, Myrina, Greece
Publication date: 2022-05-27
Public Health Toxicol 2022;2(Supplement Supplement 1):A150
Intermittent fasting diets are very popular in the last few years, due to their clinical effectiveness on subjects’ weight loss1. They are consisted of periods of eating alternating with periods of fasting2. Intermittent fasting is a generally safe type of diet, because of effects on health-related outcomes and lifestyle adherence providing, while it produces few neurological, hormonal, gastrointestinal and other metabolic adverse effects3.

Applied summarization of current evidence of the efficacy of intermittent fasting to decrease cancer risk, complications and induced biomarkers. In this aspect, many scientific databases, e.g., Google Scholar, PubMed, Google Trends, and Scopus, were comprehensively searched using relative words to identify the existing in vivo and in vitro evidence, as well as clinical trials.

Intermittent fasting may be beneficial for patients at risk for colorectal cancer because it induces autophagy, a very important process of cellular remodeling and organelle quality control4,5, which improves the in vivo inhibition of autophagy-competent tumors’ growth, by chemotherapy6. Intermittent fasting sensitizes tumors to chemotherapy and protects normal cells, including hematopoietic stem and immune cells, from its toxic side effects7. In addition, it increases the levels of bone marrow lymphoid progenitor cells and cytotoxic CD8(+) tumor-infiltrating lymphocytes, leading to major delay in breast cancer and melanoma progression7. Finally, intermittent fasting reduces chronic, low-grade inflammation, which increases the risk for many cancer types8.

Intermittent fasting diet may be a protective factor against cancer risk, inhibiting many types of cancer. There are both well-known and not well-known pathophysiological mechanisms beyond these effects, however, well-designed clinical trials for longer study periods are intensely recommended.

Mandal S, Simmons N, Awan S, Chamari K, Ahmed I. Intermittent fasting: eating by the clock for health and exercise performance. BMJ Open Sport Exerc Med. 2022;8(1):e001206. doi:10.1136/bmjsem-2021-001206
Klempel MC, Kroeger CM, Varady KA. Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet. Metabolism. 2013;62(1):137-143. doi:10.1016/j.metabol.2012.07.002
Michalsen A, Hoffmann B, Moebus S, Bäcker M, Langhorst J, Dobos GJ. Incorporation of fasting therapy in an integrative medicine ward: evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study. J Altern Complement Med. 2005;11(4):601-607. doi:10.1089/acm.2005.11.601
Su J, Braat H, Verhaar A, Peppelenbosch M. Commentary: Intermittent Fasting and Akkermansia Muciniphila Potentiate the Antitumor Efficacy of FOLFOX in Colon Cancer. Front Pharmacol. 2022;13:843133. doi:10.3389/fphar.2022.843133
Tao Z, Aslam H, Parke J, Sanchez M, Cheng Z. Mechanisms of autophagic responses to altered nutritional status. J Nutr Biochem. 2022;103:108955. doi:10.1016/j.jnutbio.2022.108955
Pietrocola F, Pol J, Vacchelli E, et al. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell. 2016;30(1):147-160. doi:10.1016/j.ccell.2016.05.016
Di Biase S, Lee C, Brandhorst S, et al. Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity. Cancer Cell. 2016;30(1):136-146. doi:10.1016/j.ccell.2016.06.005
Jordan S, Tung N, Casanova-Acebes M, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178(5):1102-1114.e17. doi:10.1016/j.cell.2019.07.050
Journals System - logo
Scroll to top